Guidelines for Corticosteroid use in Treatment of DMD

Vamshi K. Rao

doi:10.15844/pedneurbriefs-30-3-4

Guidelines for Corticosteroid use in Treatment of DMD

Pediatric Neurology Briefs

Volume 30 (2016): Issue 3

By: Vamshi K. Rao

Open Access

|Jul 2016

Abstract

The guideline development subcommittee of the American Academy of Neurology has provided an update to the 2005 treatment guidelines for use of corticosteroids (CS) in Duchenne muscular dystrophy (DMD).

References

Gloss D Moxley RT 3rd Ashwal S Oskoui M Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology Neurology 2016 Feb 86 5 465 72 10.1212/WNL.0000000000002337 26833937
Open DOI Search in Google Scholar Back to article
University of Rochester Finding the Optimum Regimen for Duchenne Muscular Dystrophy (FOR-DMD) ClinicalTrials.gov [Internet] Bethesda (MD) National Library of Medicine (US) 2000- [cited 2016 Mar 16]. Available from: http://clinicaltrials.gov/show/NCT01603407 NLM Identifier: NCT01603407
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-30-3-4 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 21 - 21

Submitted on: Mar 16, 2016

Accepted on: Apr 23, 2016

Published on: Jul 6, 2016

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Corticosteroids,

Guidelines,

Duchenne muscular dystrophy

© 2016 Vamshi K. Rao, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 30 (2016): Issue 3